Physician

John Carey Fitzpatrick, MD

According to 2025 Medicare claims, John Fitzpatrick, MD (NPI: 1700440930) practices ophthalmology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Travis, TX. This provider's primary affiliated billing organization is AUSTIN RETINA ASSOCIATES PLLC (NPI: 1114999828; TIN: 74-2034080) and primary practice location at 78654-5251.

Fitzpatrick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 611 traditional Medicare patients, billed 5,730 HCPCS/CPT codes, and received $657,166 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 244 prescription claims across 110 beneficiaries totaling $6,675 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 18 records totaling $1,005. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$329K$657K2023 Medicare payment: $19,294 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $657,166 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202357140$19,294
20246115,730$657,166

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.3K$15K2020 Drug cost: $11,736 (USD; Tot_Drug_Cst)2021 Drug cost: $14,648 (USD; Tot_Drug_Cst)2022 Drug cost: $14,507 (USD; Tot_Drug_Cst)2023 Drug cost: $14,385 (USD; Tot_Drug_Cst)2024 Drug cost: $6,675 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202047104$11,736
202167199$14,648
202235117$14,507
20234689$14,385
2024110244$6,675

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye145153$123
67028Injection of drug into eye257335$97
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more127146$69
92134Imaging of retina381509$30
92250Photography of the retina179281$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate381,048$1,495
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha661,397$676
MoxifloxacinMoxifloxacin Hcl26335$585
Atropine SulfateAtropine Sulfate18553$419
Timolol MaleateTimolol Maleate221,172$264

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$1,005Regeneron Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Carey Fitzpatrick, MD?

Tedicare shows public-source Medicare data for John Carey Fitzpatrick, MD (NPI 1700440930), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Carey Fitzpatrick, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Carey Fitzpatrick, MD?

John Carey Fitzpatrick, MD is linked to AUSTIN RETINA ASSOCIATES PLLC (billing NPI 1114999828) in the available physician profile data.

Does John Carey Fitzpatrick, MD have Open Payments data?

John Carey Fitzpatrick, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.